Public–private collaborations in drug development: boosting innovation or alleviating risk?
Author:
Affiliation:
1. Department of Business Technology and Operations, Vrije Universiteit Brussel, Brussel, Belgium
2. Chair for Public, Private & Nonprofit Management, Universität Hamburg, Hamburg, Germany
3. Business Department, Vesalius College, Brussels, Belgium
Publisher
Informa UK Limited
Subject
Management of Technology and Innovation,Management Information Systems
Link
https://www.tandfonline.com/doi/pdf/10.1080/14719037.2017.1302247
Reference67 articles.
1. Does Cross-Sectoral Partnership Deliver? An Empirical Exploration of Public Service Effectiveness, Efficiency, and Equity
2. Challenges in Multiple Cross-Sector Partnerships
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cross‐Sector Partnerships to Address Societal Grand Challenges: Systematizing Differences in Scholarly Analysis;Journal of Management Studies;2024-02-19
2. Success of Drug Development for Cancer Diseases: Radicalness and Structural Holes;2024
3. Public–Private and Private–Private Collaboration as Pathways for Socially Beneficial Innovation: Evidence from Antimicrobial Drug-Development Tasks;Academy of Management Journal;2023-12-08
4. Research on the risk evaluation of urban wastewater treatment projects based on an improved fuzzy cognitive map;Sustainable Cities and Society;2023-11
5. Many are called, few are chosen: the role of science in drug development decisions;The Journal of Technology Transfer;2023-03-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3